List of Excipients in API amlodipine besylate and valsartan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing amlodipine besylate and valsartan
Detailed excipient profiles for amlodipine besylate and valsartan
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine besylate and valsartan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
amlodipine besylate and valsartan drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
amlodipine besylate and valsartan drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
amlodipine besylate and valsartan drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
amlodipine besylate and valsartan drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
amlodipine besylate and valsartan drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
amlodipine besylate and valsartan drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
amlodipine besylate and valsartan drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
amlodipine besylate and valsartan drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
amlodipine besylate and valsartan drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
amlodipine besylate and valsartan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and valsartan | 0078-0488 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| Physicians Total Care Inc | amlodipine besylate and valsartan | 54868-5997 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and valsartan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
